Among issues dividing negotiators on the WHO Pandemic Agreement Annex on Pathogen Access and Benefit Sharing (PABS) are conditions imposed to obtain access to information through the system. One issue that seems basic is whether researchers will have to register… Continue Reading
On Wednesday, 4 February 2026, Knowledge Ecology International (KEI) delivered this constituency statement on behalf of KEI, Health Action International, Global Health Council, World Council of Churches, and Oxfam International: WHO’s work in health emergencies. Our joint statement focused on… Continue Reading
On Tuesday, 3 February 2026, Knowledge Ecology International (KEI) delivered the following statement on universal health coverage. KEI will make three points. 1. There is inequality in access to small molecule drugs, far more inequality in access to biologic drugs,… Continue Reading
KEI Comments and Notice of Intent to Testify Regarding 2026 Special 301 Review: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment (Docket USTR-2025-0243) KEI_2026 Special_301_Review_Request_to_Testify_and_Comment Introduction Knowledge Ecology International (KEI) submits the… Continue Reading
In a November 25, 2025 decision in the case of
On Tuesday afternoon, 2 December 2025, Knowledge Ecology International made the following statement on copyright limitations and exceptions at the 47th session of the WIPO Standing Committee on Copyright and Related Rights. I wanted to comment first on the African… Continue Reading
On Monday, 1 December 2025, Knowledge Ecology International (KEI) delivered the following statement on the 2025 European Health Data Spaces Regulation during the afternoon ession with Relevant Stakeholders which took place at WHO headquarters in Geneva from 16:45–17.15 CET. IGWG… Continue Reading
On October 20, 2025, Knowledge Ecology International (KEI) submitted comments to the NIH in response to the Federal Register notice titled, “Prospective Grant of an Exclusive Patent License: Substituted Quinoline Analogs As Aldehyde Dehydrogenase 1A1 Inhibitors” (90 FR 47782) The… Continue Reading
On October 14, 2025, Knowledge Ecology International (KEI) provided the NIH with comments regarding the “Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Development of Zika Virus Strains for Use in Oncolytic Therapy” (90 FR 46414) to Advocate Aurora Research… Continue Reading
On September 24, 2025, Knowledge Ecology International submitted comments to the NIH regarding the “Prospective Grant of an NCI Exclusive Patent License: Use of Anti-Mesothelin Immunotoxins for the Treatment of Mesothelin-Expressing Cancers” (90 FR 43617) to Lysin Therapeutics. Although the… Continue Reading